Xoma reported $-2280000 in Net Income for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Abbvie ABBV:US $ 4490M 446M
Agenus AGEN:US $ -48.32M 17.19M
Agios Pharmaceuticals AGIO:US $ -94.77M 0.15M
Ardelyx ARDX:US $ -28.07M 8.16M
Biomarin Pharmaceutical BMRN:US $ 120.8M 178.7M
Celldex Therapeutics CLDX:US $ -23.05M 2.9M
Chimerix CMRX:US $ -24.77M 14.73M
Curis CRIS:US $ -16.11M 2.49M
Eli Lilly And LLY:US $ 1902.9M 176.8M
Emergent Biosolutions EBS:US $ -3.7M 193M
Epizyme EPZM:US $ -55.5M 4.85M
Intercept Pharmaceuticals ICPT:US $ -17.28M 19M
Life Technologies LIFE:US $ -12.15M 3.59M
Macrogenics MGNX:US $ -66.44M 8.42M
Novartis NOVN:VX SF 2222M 14086M
Novartis NVS:US $ 2222M 14086M
Pfizer PFE:US $ 7863M 4470M
Prothena PRTA:US $ -36.29M 3.11M
Regeneron Pharmaceuticals REGN:US $ 973.5M 1255.5M
Teva Pharmaceutical Industries TEVA:US $ -955M 797M
Xoma XOMA:US $ -2280000 32.12M
YTE INCY:US $ 37.99M 525.86M